AM251: Difference between revisions
Jump to navigation
Jump to search
imported>Xenbase |
imported>Xenbase |
||
Line 1: | Line 1: | ||
==Description== | ==Description== | ||
AM251, is a CB1 cannabinoid receptor antagonist | AM251, is a CB1 cannabinoid receptor antagonist. | ||
==Synonyms== | ==Synonyms== | ||
AM-251; 183232-66-8; AM 251; UNII-3I4FA44MAI; 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide. | AM-251; 183232-66-8; AM 251; UNII-3I4FA44MAI; 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide. |
Latest revision as of 06:28, 23 June 2017
Description
AM251, is a CB1 cannabinoid receptor antagonist.
Synonyms
AM-251; 183232-66-8; AM 251; UNII-3I4FA44MAI; 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide.
Suppliers
Usage Notes
References
>9 Xenbase articles contain a reference to AM251 according to textpresso